Inhibition of proliferation in primary human hepatocytes following in vivo AAV-mediated genome editing

被引:0
作者
Amaya, A. K. [1 ]
Ginn, S. L. [1 ]
Liao, S. H. Y. [1 ]
Zhu, C. [1 ]
Smyth, C. M. [1 ]
Logan, G. J. [1 ]
Lisowski, L. [1 ]
Alexander, I. E. [1 ]
机构
[1] Childrens Med Res Inst, Westmead, NSW, Australia
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
OR50
引用
收藏
页码:A18 / A18
页数:1
相关论文
共 50 条
[31]   AAV-mediated gene expression and deletion in cardiac fibroblasts in vivo [J].
Nieto, Bridget ;
Cypress, Michael ;
O-Uchi, Jin ;
Jhun, Bong Sook .
PHYSIOLOGY, 2023, 38
[32]   Efficient in vivo editing of patient-derived primary human hepatocytes [J].
Ginn, S. L. ;
Amaya, A. K. ;
Liao, S. H. Y. ;
Zhu, E. ;
Cunningham, S. C. ;
Hallwirth, C. V. ;
Tay, S. S. ;
Lee, M. ;
Pickett, H. A. ;
Grompe, M. ;
Dilworth, K. ;
Lisowski, L. ;
Alexander, I. E. .
HUMAN GENE THERAPY, 2019, 30 (08) :A2-A3
[33]   Successful in vivo editing of patient-derived primary human hepatocytes [J].
Amaya, A. K. ;
Ginn, S. L. ;
Liao, S. H. Y. ;
Zhu, C. ;
Lee, M. ;
Pickett, H. A. ;
Hallwirth, C. V. ;
Cunningham, S. C. ;
Lisowski, L. ;
Alexander, I. E. .
HUMAN GENE THERAPY, 2018, 29 (12) :A26-A27
[34]   AAV-mediated gene targeting methods for human cells [J].
Khan, Iram F. ;
Hirata, Roli K. ;
Russell, David W. .
NATURE PROTOCOLS, 2011, 6 (04) :482-501
[35]   AAV-mediated gene editing of type 1 collagen mutation for Osteogenesis Imperfecta [J].
Yang, Yeon-Suk ;
Sato, Tadatoshi ;
Chaugule, Sachin ;
Chen, Zhihao ;
Rodriguez, Agustina ;
Ma, Hong ;
Xie, Jun ;
Gao, Guangping ;
Shim, Jae-Hyuck .
JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 :232-233
[36]   AAV-mediated gene targeting methods for human cells [J].
Iram F Khan ;
Roli K Hirata ;
David W Russell .
Nature Protocols, 2011, 6 :482-501
[37]   AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria [J].
Richards, Daelyn Y. ;
Winn, Shelley R. ;
Dudley, Sandra ;
Nygaard, Sean ;
Mighell, Taylor L. ;
Grompe, Markus ;
Harding, Cary O. .
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 17 :234-245
[38]   AAV-Mediated Gene Targeting Is Significantly Enhanced by Transient Inhibition of Nonhomologous End Joining or the Proteasome In Vivo [J].
Paulk, Nicole K. ;
Loza, Laura Marquez ;
Finegold, Milton J. ;
Grompe, Markus .
HUMAN GENE THERAPY, 2012, 23 (06) :658-665
[39]   DNA/RNA hybrids as double edge sword: r-loops can influence the efficiency of AAV-mediated genome editing and undesired vector integrations in vivo [J].
Puzzo, F. ;
Crossley, M. P. ;
Goswami, A. ;
Pekrun, K. ;
Zhang, F. ;
Cimprich, K. ;
Kay, M. A. .
HUMAN GENE THERAPY, 2024, 35 (3-4) :A9-A9
[40]   AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia [J].
Waqas Nawaz ;
Bilian Huang ;
Shijie Xu ;
Yanlei Li ;
Linjing Zhu ;
Hu Yiqiao ;
Zhiwei Wu ;
Xilin Wu .
Blood Cancer Journal, 11